Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes
Roberto Piva(University of Turin), Giorgio Inghirami(Cornell University)
Cited by 164
Related Papers
Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors
|Hybridoma|1984|580
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
|Blood|2003|247